Literature DB >> 25539471

Comparative analysis of lipotoxicity induced by endocrine, pharmacological, and innate immune stimuli in rat basophilic leukemia cells.

Kristina Maaetoft-Udsen1, William E Greineisen, Johnny Tudela Aldan, Hazelle Magaoay, Cheryll Ligohr, Lori M N Shimoda, Carl Sung, Helen Turner.   

Abstract

Cellular lipotoxicity manifests as the steatotic accumulation of lipid droplets or lipid bodies, and/or induction of phospholipidosis. Lipotoxicity can be induced by hyperinsulinemia/nutrient overload, cationic amphiphilic drugs (CAD), and innate immunological stimuli, all of which are stimuli relevant to mast cell physiology. Hyper-accumulation of mast cell lipid bodies in response to hyperinsulinemia has been documented, but lipotoxicity in response to CAD or innate immunologic stimuli has not been analysed comparatively. Moreover, gaps in our understanding of this steatosis remain, specifically as to whether hyperinsulinemia-driven steatosis in these cells attains lipotoxic levels or is accompanied by phospholipidosis. To compare endocrine, pharmacological, and innate immunological stimuli for their ability to induce steatosis and phospholipidosis in a rat basophilic leukemia mast cell model (RBL2H3), differential fluorescence microscopy staining and quantitation of phospholipidosis and steatosis in the RBL2H3 cell line was examined. The three classes of stimuli differentially induced phospholipidosis and steatosis. PPARγ up-regulation was not uniformly associated with the expansion of the lipid body population. Fluorescence imaging of lipid-enriched structures generated in response to lipotoxic cationic amphiphilic drugs, chronic insulin exposure, and TLR2/4 ligands revealed differential staining patterns when visualized using lipophilic dyes. It is concluded that lipotoxicity-inducing pathways in this model mast cell system are diverse, and include steatotic responses to an endocrine stimulus, as well as phospholipidosis responses to cationic lipophilic drugs not previously described in this cell type.

Entities:  

Keywords:  Lipotoxicity; mast cells; phospholipidosis; steatosis

Mesh:

Substances:

Year:  2014        PMID: 25539471      PMCID: PMC4755781          DOI: 10.3109/1547691X.2014.990655

Source DB:  PubMed          Journal:  J Immunotoxicol        ISSN: 1547-691X            Impact factor:   3.000


  35 in total

Review 1.  The life of lipid droplets.

Authors:  Tobias C Walther; Robert V Farese
Journal:  Biochim Biophys Acta       Date:  2008-11-07

2.  Giant phospholipid vesicles: comparison among the whole lipid sample characteristics using different preparation methods: a two photon fluorescence microscopy study.

Authors:  L A Bagatolli; T Parasassi; E Gratton
Journal:  Chem Phys Lipids       Date:  2000-04       Impact factor: 3.329

3.  The phospholipid monolayer associated with perilipin-enriched lipid droplets is a highly organized rigid membrane structure.

Authors:  Stephen M Storey; Avery L McIntosh; Subramanian Senthivinayagam; Kenneth C Moon; Barbara P Atshaves
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-16       Impact factor: 4.310

4.  A fluorogenic phospholipid for the detection of lysosomal phospholipase A2 activity.

Authors:  Akira Abe; Piotr W Rzepecki; James A Shayman
Journal:  Anal Biochem       Date:  2012-11-09       Impact factor: 3.365

5.  Insulin-containing lipogenic stimuli suppress mast cell degranulation potential and up-regulate lipid body biogenesis and eicosanoid secretion in a PPARγ-independent manner.

Authors:  William E Greineisen; Lori M N Shimoda; Kristina Maaetoft-Udsen; Helen Turner
Journal:  J Leukoc Biol       Date:  2012-06-15       Impact factor: 4.962

6.  In vitro validation of drug-induced phospholipidosis.

Authors:  Sora Park; You-Jin Choi; Byung-Hoon Lee
Journal:  J Toxicol Sci       Date:  2012       Impact factor: 2.196

7.  High-content imaging of neutral lipid droplets with 1,6-diphenylhexatriene.

Authors:  Max V Ranall; Brian G Gabrielli; Thomas J Gonda
Journal:  Biotechniques       Date:  2011-07       Impact factor: 1.993

Review 8.  Drug induced phospholipidosis: an acquired lysosomal storage disorder.

Authors:  James A Shayman; Akira Abe
Journal:  Biochim Biophys Acta       Date:  2012-08-30

9.  The internal architecture of leukocyte lipid body organelles captured by three-dimensional electron microscopy tomography.

Authors:  Rossana C N Melo; Guillherme F Paganoti; Ann M Dvorak; Peter F Weller
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Identification of drugs inducing phospholipidosis by novel in vitro data.

Authors:  Markus Muehlbacher; Philipp Tripal; Florian Roas; Johannes Kornhuber
Journal:  ChemMedChem       Date:  2012-09-03       Impact factor: 3.466

View more
  4 in total

1.  Human amnion mesenchymal cells are pro-inflammatory when activated by the Toll-like receptor 2/6 ligand, macrophage-activating lipoprotein-2.

Authors:  Brittany L Sato; Eric S Collier; Sheryl Anne Vermudez; Anthony D Junker; Claire E Kendal-Wright
Journal:  Placenta       Date:  2016-06-11       Impact factor: 3.481

2.  Transcriptional and Functional Plasticity Induced by Chronic Insulin Exposure in a Mast Cell-Like Basophilic Leukemia Cell Model.

Authors:  Chad Jansen; Mark Speck; William E Greineisen; Kristina Maaetoft-Udsen; Edward Cordasco; Lori Mn Shimoda; Alexander J Stokes; Helen Turner
Journal:  J Immunobiol       Date:  2017-12-11

3.  Insulin-induced lipid body accumulation is accompanied by lipid remodelling in model mast cells.

Authors:  Johnny T Aldan; Chad Jansen; Mark Speck; Kristina Maaetoft-Udsen; Edward A Cordasco; Mata'Uitafa Faiai; Lori M N Shimoda; William E Greineisen; Helen Turner; Alexander J Stokes
Journal:  Adipocyte       Date:  2019-12       Impact factor: 4.534

Review 4.  Detection of Lipid and Amphiphilic Biomarkers for Disease Diagnostics.

Authors:  Jessica Z Kubicek-Sutherland; Dung M Vu; Heather M Mendez; Shailja Jakhar; Harshini Mukundan
Journal:  Biosensors (Basel)       Date:  2017-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.